Dear SCMR Members,
#SCMR2021 will be about Precise, Predictive, and Personal cardiovascular imaging. The conference will feature exciting plenary and focus sessions on the role of CMR in imaging patients with COVID-19. Educational sessions will highlight the expanding role of CMR in clinical cardiovascular medicine around the world. Technologically oriented sessions will focus on recent discoveries in CMR. Early career and professional development sessions will assist those new and experienced in CMR develop and expand their practice. On behalf of the Program Committee, I look forward to welcoming all of you to the #SCMR2021 Scientific Sessions!
Sincerely,
Christopher Francois
Chair, SCMR Program Committee
|
|
|
Dear Colleagues,
We are pleased to share an update on the SCMR Registry. The Registry is a repository of clinical data, finalized reports, and follow up data. However, what sets the Registry apart from other databases, is that it also includes all the CMR images. In total, the Registry now includes 110,000 scans, 200 million images, and 334,000 patient-years of follow-up across 13 sites with several new participating centers pending addition.
|
|
|
A number of research projects that leverage the unique data in the Registry are underway. These projects encompass a variety of topics, including congenital heart disease, valvular heart disease, coronary artery disease, and cardiomyopathy. We encourage the entire SCMR community to support and participate in the Registry.
The Registry webpage (https://scmr.org/page/Registry) provides step-by-step instructions on how to participate and contribute to the Registry. You will also be able to view the on-going active research projects with descriptions and find instructions on how to start a new investigation.
Active Research Projects:
- Sex-based Differences in Left Ventricular Remodeling in Patients with Chronic Aortic Regurgitation
- Prevalence and Prognostic Significance of Small Myocardial Infarcts Detected by CMR in 18,000 Patients with Normal Contractile Function: A Multicenter Study with Ten Years of Follow-up
- Cardiac Magnetic Resonance to Assess Impact of Aortic Regurgitation and Myocardial Scar on Clinical Outcomes The AR SCAR Multicenter Study
- Tetralogy of Fallot Biventricular Shape Atlas
- Using Neural Networking to Develop a Novel Cardiac Magnetic Resonance-based Model to Predict Cardiac Amyloid Subtype
Please contact us if you have any questions!
On behalf of the Registry Committee,
|
|
|
Han Kim, Vice Chair
Orlando Simonetti, Chair
|
|
|
SCMR Position Paper (2020) on Clinical Indications for Cardiovascular Magnetic Resonance
by Tim Leiner on behalf of the co-authors Jan Bogaert, Matthias G. Friedrich, Raad Mohiaddin, Vivek Muthurangu, Saul Myerson, Andy Powell, Subha Raman and Dudley Pennell
|
After two years of hard work, we are pleased to announce the that the completely revised and updated 2020 version of the SCMR “Position Paper on clinical indications for cardiovascular magnetic resonance” has been published! In the document up to date indications for CMR in patients with congenital heart disease, acquired vascular disease, coronary artery disease, myocarditis and other cardiomyopathies, pericardial disease, cardiac masses and valvular heart disease are discussed. This new document replaces the prior 2004 version of the document. New scan techniques and lots of new evidence on the value of CMR across all of these indications have been incorporated in the new document. We hope the document will serve as an important resource to all stakeholders involved in CMR and that it will convince clinical colleagues of the critical role of the technique in modern cardiovascular medicine.
We welcome your feedback!
|
|
|
New AHA/ACC Hypertrophic Cardiomyopathy Guidelines |
New 2020 AHA/ACC guidelines for diagnosis & treatment of patients with hypertrophic cardiomyopathy were published this month (ahead of print). Since the last iteration of these guidelines in 2011, there has been a great deal of new evidence in HCM relating to the role of all diagnostic imaging modalities, genetic testing, medical therapies, septal reduction therapies, sudden cardiac death risk assessment and lifestyle considerations. CMR assessment includes anatomical, functional & tissue characterization all of which is well-suited for characterizing the diverse phenotypic expressions of HCM, providing diagnosis, risk prediction, and preprocedural planning for septal reduction. For these reasons, the role of CMR has been consolidated with 4 important class I recommendations in these new guidelines as detailed below (an increase from 2 class I indications in 2011).
|
|
|
The Australia New Zealand Working Group for Cardiac MRI- ANZCMR
|
|
|
Australia and New Zealand have seen steady growth in CMR activity. We have had a successful application for reimbursement of scans for patients with ARVC and their relatives. Until now, this has not been funded, which limited the availability of services.
Both nations also collaborated to form a Conjoint Committee for Certification in Cardiac MRI, with representatives from the Cardiac Society of ANZ, the Royal Australasian College of Radiologists, and the ANZCMR. The certification requirements were modelled on the SCMR and ECR requirements, but with some differences due to regional workforce and remote community issues in our countries (which have lower population density than USA/Europe).
|
|
|
We have now certified over 100 specialists grandfathered as “expert providers” which is SCMR Level 3 equivalency, and we hope to offer a certification exam in the future.
Future directions for Australia New Zealand: we hope to apply for CMR reimbursement for stress perfusion, complex congenital, and cardiomyopathies, and will continue to run our annual educational meeting “CMR Australia” under the endorsement of the SCMR.
|
|
|
John Younger
ANZCMR President
Christian Hamilton-Craig
ANZCMR ex-officio Past President
Chair of Conjoint Committee for CMR Certification
|
|
|
Send us Your Success Stories! |
|
|
SCMR would like to hear about your own local success stories – small, big or massive! Examples include a new service, clinical developments or research success.
Please submit some brief initial details and we will contact you for further information if there is scope to include in the monthly newsletter.
|
|
|
The SCMR "How I Do" CMR Series |
The SCMR "HOW I DO" CMR Series is a members only educational series demonstrating how specific CMR scans are performed.* The series is coordinated and developed by the SCMR Clinical Practice Committee.
Find the newest presentations below:
|
This presentation covers:
- When to perform the myocarditis protocol
- Diagnostic targets
- Updated Lake Louise Criteria (2018)
- Image analysis
- Reporting
- Integration of results into clinical decisions
|
|
|
This presentation covers:
- Algorithm for the Integration of Parameters of AR Severity
- Cardiac MR Provides Comprehensive Assessment for Valvular Regurgitation
- CMR Assessment of AR: Pulse Sequences
- Determining Mechanism of Aortic Regurgitation (AR)
- Quantitating AR Severity
- Determining Consequence of AR
- Magnetic Resonance Angiography
- When is CMR Indicated in Aortic Regurgitation?
|
|
|
Congenital CMR Case Conference (C4)
12 pm ET on Wednesday December 9, 2020
|
This one-hour video conference is packed with interesting, challenging, and enlightening congenital cardiac cases with the main theme of Machine learning in Cardiac MRI.
Audience participation and moderator discussion will be geared towards practical tips from experts, new techniques, and trouble-shooting.
Your hosts Dr. LaDonna Malone and Dr. Sujatha Buddhe will introduce expert guest speakers who bring a wealth of experience.
This will be an interactive panel discussion with presentations by:
|
|
|
Prof. Daniel Rueckert
Imperial College London
Basics of Machine Learning for Clinicians
|
|
Dr. Jennifer Steeden
University College London
Applications of Machine Learning in
MRI for Congenital Heart Disease
|
|
|
Who is this for?
Trainees, new practitioners, and experts should all find value in this conference.
Please RSVP to the link below by December 7 and we will send you instructions about how to join in advance of the conference.
|
|
|
-
Physics (CME): Basic magnetic resonance physics, basic pulse sequences, advanced pulse sequences, and safety
|
|
|
Thursday, December 10 @ 11 am ET
Parallel imaging is essential for modern CMR, enabling the speed required for high-quality dynamic imaging. This seminar will describe the basic mechanics of parallel imaging and how it is used in cardiac MR, with an emphasis on providing a conceptual understanding of both SENSE and GRAPPA. Emerging technologies using parallel imaging, and their potential applications, will also be discussed.
|
|
|
Presenter:
Nicole Seiberlich, Associate Professor and Co-Director of the Michigan Institute for Imaging Technology and Translation MIITT) @Department of Radiology, University of Michigan
|
|
|
Wednesday, December 2 @ 11 am ET
Abnormal Papillary Muscle Signal on Cine MRI as a Typical
Feature of Mitral Valve Prolapse
Scatteia, et. al
&
Hemorrhage Promotes Chronic Adverse Remodelling in Acute
Myocardial Infarction: a T1, T2 and BOLD Study
Assimopoulos, et. al
|
|
|
with Moderator Scott Flamm
Wednesday, December 9 @ 11 am ET
Accelerated High-resolution Free-breathing 3D Whole-heart T2-prepared Black-blood and Bright-blood Cardiovascular Magnetic Resonance
Presenting Authors: Dr. Teresa Correia and Dr. Claudia Prieto
|
|
|
November 25 - December 11, 2020
Mexico City, Mexico
100% Online
This online course will develop skills, increase the knowledge of attendees in various areas of related to imaging and technology in Cardiology and promote interaction between the various branches of cardiology to exchange and enrich knowledge and experiences. Find more information here.
|
|
|
The introduction in clinical Cardiology of Cardiac Magnetic Resonance Imaging has opened extraordinary opportunities both for the understanding and the treatment of a large variety of cardiac diseases. In fact, Cardiac Magnetic Resonance Imaging can be considered, at all the effects, a sort of Cardiac Pathology in vivo and, because of this potential, is nowadays considered essential for the management of some cardiac diseases. A unique potential of Cardiac Magnetic Resonance Imaging is represented by the capacity of identifying the myocardial substrate for arrhythmias in a large variety of diseases characterized by the presence of severe, sometimes lethal, ventricular arrhythmias.
If you'd like your meeting to be endorsed by SCMR, click here for details.
|
|
|
 |
A 52-year old female without prior medical history was admitted with Influenza A myocarditis progressing to cardiogenic shock. She eventually required extracorporeal membrane oxygenation for biventricular failure on multiple inotropic medications. Nine days into admission, she received implantation of a HeartMate II left ventricular assist device (LVAD) and was subsequently discharged.
|
|
|
|
|
October 20 to November 18, 2020
#WhyCMR Activity
by Daniel Lorenzatti
|
Each month our social media committee correspondents update us on the latest #WhyCMR activity stats, most popular tweets or threads. Join the conversation and use the #WhyCMR in your social media posts! |
|
|
|
|
|
|
What well known MRI pulse sequence is illustrated?
Answer available next month.
|
|
|
|
Last month's CMR Picture Puzzle answer:
Steady State Free Precession
|
|
|
|
Review
Tim Leiner, et al.
Published on: 09. November 2020
|
|
Review
Lars Grosse-Wortmann, et al.
Published on: 29. October 2020
|
|
Research
Andrew J. Patterson, et al.
Published on: 12. October 2020
|
|
Research
Shingo Kato, et al.
Published on: 08. October 2020
|
|
Research
Francesco Santini, et al.
Published on: 05. October 2020
|
|
Review
Chiara Bucciarelli-Ducci, et al.
Published on: 28. September 2020
|
|
Please use this link for a filtered PubMed list of all CMR-related manuscripts for November 2020 – more than 200 in total!
|
|
Manish Motwani
Newsletter Editor
|
|
|
|
|
|
|
|
|
